1. Home
  2. APPN vs ALVO Comparison

APPN vs ALVO Comparison

Compare APPN & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Appian Corporation

APPN

Appian Corporation

HOLD

Current Price

$27.15

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$4.15

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APPN
ALVO
Founded
1999
2013
Country
United States
Luxembourg
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
APPN
ALVO
Price
$27.15
$4.15
Analyst Decision
Hold
Buy
Analyst Count
6
4
Target Price
$33.83
$9.25
AVG Volume (30 Days)
1.4M
498.1K
Earning Date
05-21-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
101.59
N/A
EPS
0.02
N/A
Revenue
$226,743,000.00
N/A
Revenue This Year
$12.18
$20.85
Revenue Next Year
$11.43
$44.49
P/E Ratio
$1,316.50
$18.20
Revenue Growth
28.29
N/A
52 Week Low
$21.77
$3.93
52 Week High
$46.06
$11.85

Technical Indicators

Market Signals
Indicator
APPN
ALVO
Relative Strength Index (RSI) 51.77 30.07
Support Level $21.77 N/A
Resistance Level $31.83 $5.46
Average True Range (ATR) 1.65 0.25
MACD 0.61 -0.08
Stochastic Oscillator 93.08 16.00

Price Performance

Historical Comparison
APPN
ALVO

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

About ALVO Alvotech

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

Share on Social Networks: